Cambridge Scientists Get £41M Boost for Cancer Research
Cambridge scientists are set to receive a major cash injection from Cancer Research UK, which has announced plans to invest over £41 million over the next five years at the Cancer Research UK Cambridge Centre, one of the University of Cambridge’s Strategic Research Initiatives. The funding will help support ground-breaking work as part of the development of a unique chain of research hubs around the UK.
A key part of the funding will involve training the next generation of cancer researchers - including 45 PhD students - to ensure the brightest scientists are attracted to Cambridge.
The award will also fund research nurses and data managers, and help build patient groups, and facilitate tissue sample collection and processing which is essential for life saving research.
Professor Richard Gilbertson, Director of the Cancer Research UK Cambridge Centre, said: “This funding award is excellent news for the city and for our Centre. It represents a critical investment in the research infrastructure in Cambridge and will equip us with the key laboratory and clinical tools needed to advance the understanding and treatment of cancer.
“This is an exciting collaboration of researchers, scientists and clinicians from Cancer Research UK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust as well as the pharmaceutical and biotechnology companies across the city. It’s an alliance that allows us to make use of a wide range of expertise and techniques that can help progress cancer research and bring benefits to patients sooner.
“The investment means we will be able to further develop our work in translational research – getting cutting-edge discoveries from the laboratory to patients and learning as much as possible from patients to initiate new research.”
The Centre brings together leading scientists, doctors and nurses to push forward improvements in early diagnosis and to find and develop better, kinder treatments. In particular, researchers are focusing on breast, lung, ovarian, pancreatic, oesophageal, blood, prostate and children’s cancers and brain tumours.
Danielle Glavin, Cancer Research UK spokesperson for the East, said: “This award is a recognition of the fantastic research that’s taking place in Cambridge. One in two of us will be diagnosed with cancer at some point in our lives - so it’s reassuring to know that, thanks to our supporters, Cancer Research UK is able to fund some of the best and most promising research in Cambridge that will help more people survive.”
Cellular Valve Structure Opens Up Potential Novel TherapiesNews
Biochemists have determined the detailed structure of a volume-regulated chloride channel. This cellular valve is activated in response to swelling to prevent the cell from bursting. The protein also plays an important role in the uptake of chemotherapeutics and the release of neurotransmitters after a stroke. The controlled regulation of its activity thus opens up a promising strategy for novel therapies.READ MORE
Algorithm Predicts Life Expectancy After Heart AttackNews
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.